Elekta AB (publ) (OTCMKTS:EKTAY) Short Interest Down 99.5% in January

Elekta AB (publ) (OTCMKTS:EKTAYGet Free Report) saw a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 100 shares, a decrease of 99.5% from the January 15th total of 19,700 shares. Based on an average daily volume of 16,900 shares, the days-to-cover ratio is presently 0.0 days.

Analyst Ratings Changes

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a report on Wednesday, January 29th.

Read Our Latest Analysis on EKTAY

Elekta AB (publ) Stock Performance

OTCMKTS EKTAY opened at $6.00 on Thursday. The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $2.30 billion, a price-to-earnings ratio of 23.98 and a beta of 1.22. The firm’s 50 day simple moving average is $5.66 and its 200 day simple moving average is $6.09. Elekta AB has a 1 year low of $5.25 and a 1 year high of $8.24.

Elekta AB (publ) (OTCMKTS:EKTAYGet Free Report) last issued its earnings results on Wednesday, November 27th. The company reported $0.06 earnings per share for the quarter. Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. As a group, research analysts expect that Elekta AB will post 0.36 earnings per share for the current fiscal year.

Elekta AB (publ) Cuts Dividend

The company also recently announced a dividend, which will be paid on Thursday, March 27th. Investors of record on Friday, March 7th will be paid a dividend of $0.1072 per share. The ex-dividend date is Friday, March 7th. Elekta AB (publ)’s dividend payout ratio is presently 48.00%.

About Elekta AB (publ)

(Get Free Report)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

Read More

Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.